Hennion & Walsh Asset Management Inc. Has $695,000 Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
Hennion & Walsh Asset Management Inc. increased its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 89.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,315 shares of the company’s stock after purchasing an additional 7,235 shares during the period. […]
More Stories
Bone ShibaSwap (BONE) Price Hits $0.40 on Major Exchanges
Bone ShibaSwap (BONE) traded down 0.1% against the US dollar during the 1-day period ending at 22:00 PM E.T. on...
Blue Trust Inc. Grows Stock Holdings in Chevron Co. (NYSE:CVX)
Blue Trust Inc. boosted its stake in shares of Chevron Co. (NYSE:CVX – Free Report) by 27.3% during the third...
Jet Protocol (JET) Price Reaches $0.0001
Jet Protocol (JET) traded up 0% against the U.S. dollar during the 24-hour period ending at 22:00 PM E.T. on...
LayerZero (ZRO) Trading 5.4% Lower This Week
LayerZero (ZRO) traded down 2.5% against the U.S. dollar during the one day period ending at 22:00 PM Eastern on...
Qubic (QUBIC) Trading Down 6.7% This Week
Qubic (QUBIC) traded down 0.9% against the dollar during the 24 hour period ending at 22:00 PM ET on October...
BinaryX One Day Trading Volume Hits $247,662.39 (BNX)
BinaryX (BNX) traded up 1.2% against the US dollar during the 1 day period ending at 22:00 PM E.T. on...